|国家科技期刊平台
首页|期刊导航|中国药理学与毒理学杂志|病毒载体遗传毒性评价方法研究进展

病毒载体遗传毒性评价方法研究进展OA北大核心CSTPCD

Progress in genotoxicity evaluation methods of viral vectors

中文摘要英文摘要

随着基因治疗产品逐渐进入市场,迫切需要建立病毒载体介导的遗传毒性评价方法.目前应用广泛的病毒载体主要有2种:慢病毒载体和腺相关病毒载体.慢病毒载体能够稳定整合到宿主基因组中;而腺相关病毒载体基因组在宿主细胞核中主要以附加体形式存在,仍能以低频率随机整合到宿主细胞基因组中,其整合方式包括随机整合和靶向整合.本文对已有的病毒载体介导的遗传毒性评价方法,包括脱靶修饰的全基因组分析、整合位点分析、核型分析和评估细胞转化潜力试验等进行综述,并对建立准确快速的病毒载体介导的遗传毒性的评价体系予以展望,以期为进一步完善和研发新的病毒载体遗传毒性评价方法提供参考.

With the gradual entry of gene therapy products into the market,there is an urgent need to establish viral vector-mediated genotoxicity evaluation methods.The two most widely used viral vectors are lentiviral vectors and adeno-associated viral vectors.Lentiviral vectors can stably integrate into the host genome while the viral vector genome mainly exists in the form of episomes in the nucleus of the host cell,and can still be randomly integrated into the host cell genome at a low frequency,the integra-tion modes for which include random integration and targeted integration.This paper reviews the existing methods for evaluating the genotoxicity mediated by viral vectors,including whole-genome analysis of off-target modifications,integration site analysis,karyotype analysis,and tests to assess the potential for cell transformation.This article also offers a vision of the establishment of an accurate and rapid evaluation system for viral vector-mediated genotoxicity in the hopes of providing reference for improvement and development of new methods for evaluating the genotoxicity of viral vectors.

何伟伟;周长慧;郑明岚;李嫚琪;崔文腾;方雅励;王晓炜;常艳

中国医药工业研究总院,上海益诺思生物技术股份有限公司,上海 201203国家药品监督管理局药品审评检查长三角分中心,上海 201203深圳市药品检验研究院,广东深圳 518057

药学

基因治疗病毒载体整合遗传毒性

gene therapyviral vectorintegrationgenotoxicity

《中国药理学与毒理学杂志》 2024 (004)

314-320 / 7

上海市科委研发公共服务平台项目(21DZ2291000) Shanghai Municipal Science and Technology Commission R&D Public Service Platform Project(21DZ2291000)

10.3867/j.issn.1000-3002.2024.04.009

评论